Composition

levothyroxine sodium 100 mkg

Other ingredients: calcium hydrogen phosphate dihydrate, microcrystalline cellulose, sodium carboxymethyl starch (type A), dextrin, long-chain partial glycerides

Mode of action

Synthetic thyroid hormone drug, laevorotatory isomer of thyroxine. After partial conversion to triiodothyronine (liver and kidney) and enter the cells of the body, it affects the development and growth of tissue metabolism.

In small doses it has anabolic effect on protein and fat metabolism. In high doses, stimulates the growth and development, increase tissue oxygen demand, stimulates the metabolism of proteins, fats and carbohydrates, increases the functional activity of the cardiovascular system and CNS. In high doses, it inhibits the production TTRG hypothalamus and pituitary TSH.

The therapeutic effect is observed after 7-12 days, during the same time saved effect after discontinuation of the drug. The clinical effect of hypothyroidism is manifested through 3-5 diffuse goiter is reduced or disappears within 3-6 months.

testimony

- Hypothyroidism;

- Euthyroid goiter;

- As replacement therapy and for the prevention of goiter recurrence after resection of the thyroid gland;

- Thyroid cancer (after surgery);

- Diffuse toxic goiter: after achieving euthyroid state tireostatikami (in the form of combination or monotherapy);

- As a diagnostic tool for the test suppression of thyroid

Contraindications

- Untreated hyperthyroidism

- Acute myocardial infarction, acute myocarditis;

- Untreated adrenal insufficiency function;

- Increased individual sensitivity to the drug.

Precautions should be prescribed the drug for ischemic heart disease (atherosclerosis, angina pectoris, myocardial infarction), hypertension, arrhythmia, diabetes, severe long-existing hypothyroidism, malabsorption syndrome (may require dose adjustment).

Drug interactions

Levothyroxine increases the effects of anticoagulants, which may require a reduction in their dose.

The use of tricyclic antidepressants with levothyroxine may result in increased action of antidepressants.

Thyroid hormones may increase the need for insulin and oral hypoglycemic drugs. More frequent monitoring of blood glucose is recommended during periods of initiation of treatment with levothyroxine, as well as a change in dose.

Levothyroxine reduces the effect of cardiac glycosides. With simultaneous use of cholestyramine, colestipol and aluminum hydroxide reduces the plasma concentration of levothyroxine by its inhibition of absorption in the intestine.

While the use of anabolic steroids, asparaginase, tamoxifen possible pharmacokinetic interaction at the level of protein binding.